384. Factors Potentiating the Risk of Linezolid-induced Thrombocytopenia in Patients without Haemato-oncologic Diseases: A Case-control Study

BACKGROUND: Thrombocytopenia is a major adverse effect of linezolid due to myelosuppression. Many studies assessed factors associated with this effect, but most included patients with haemato-oncologic diseases, which may confound the assessment of thrombocytopenia. Therefore, this study aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Thabit, Abrar K, Alghamdi, Arwa A, Alsaeed, Afnan K, Magbool, Nesreen M, Mahrous, Ahmad J, Alrowaili, Alya, Alsowaida, Yazed S, Albakistani, Ziyad K, Albangali, Basem O, Alghumuy, Anas M, Youssef, Sara A, Alodayli, Reem M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678807/
http://dx.doi.org/10.1093/ofid/ofad500.454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678807/
http://dx.doi.org/10.1093/ofid/ofad500.454

Ejemplares similares